Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Alia Therapeutics logo — On-target gene therapies

Alia Therapeutics

On-target gene therapies

Founded 2018 Italy Italy 15 employees Seed Total: $5.70M Biotechnology, Health and Wellness

General Information

Company Name Alia Therapeutics
Founded Year 2018
Location Italy Italy
Employees 15
Industries Biotechnology, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Alia Therapeutics. To contact Alia Therapeutics, visit aliatherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Alia Therapeutics compare?

A PDF of Alia Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Alia Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Alia Therapeutics

Alia Therapeutics is a biotechnology startup based in Italy, founded in 2018, which has recently attracted a significant €4.40M investment in a Seed Round at 17 April 2023. This investment was led by Sofinnova Partners, Indaco Venture Partners, and BiovelocITA. The company is focused on developing on-target gene therapies using novel CRISPR systems, aiming to revolutionize medicine by addressing genetic diseases at their roots. With a versatile portfolio of CRISPR systems, Alia is expanding the range of targetable genomic sites and increasing the precision of genetic modifications. This enables the company to take gene editing to a new level of specificity and safety, crucial for therapeutic applications. Alia Therapeutics is positioned at the forefront of the rapidly evolving gene editing and biotechnology fields, making it a compelling prospect for potential investors.

Business keywords: Gene therapy, CRISPR, Genome editing, Genetic diseases, Rare diseases, Therapeutic approaches, Italian biotech, Biomedical technology, Genetic medicine, Incurable diseases

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round €4.40M 3
Sofinnova Partners Indaco Venture Partners
Sofinnova Partners, Indaco Venture Partners +1
17 Apr 2023
Seed Round Undisclosed 1
Sofinnova Partners
Sofinnova Partners
30 Jun 2021
Seed Round €1.30M 2
Trentino Invest Srl
Trentino Invest Srl, BiovelocITA
08 Apr 2019

Alia Therapeutics Alternatives & Competitors

View All Alternatives
Alia Therapeutics vs
Tevard Biosciences
Tevard Biosciences United States

Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases.

27 employees
Biotechnology, Health and Wellness
Alia Therapeutics vs
Excision BioTherapeutics
Excision BioTherapeutics United States

Developing CRISPR-based therapies intended to cure viral infectious diseases.

Grant
24 employees
Biotechnology, Health Care
Alia Therapeutics vs
Locanabio, Inc.
Locanabio, Inc. United States

Creating RNA-targeting gene therapies to treat devastating diseases

Series B
7 employees
Biotechnology, Health Care
View all alternatives

FAQ About Alia Therapeutics

On-target gene therapies
Alia Therapeutics was founded in 2018.
Alia Therapeutics is headquartered in Italy.
Alia Therapeutics operates in Biotechnology and Health and Wellness. Its work centres on Gene therapy, CRISPR, Genome editing and Genetic diseases.
Alia Therapeutics has approximately 15 employees.
Alia Therapeutics has completed 3 funding rounds, raising a total of $5.70M. The latest funding stage is Seed.
Top alternatives and competitors to Alia Therapeutics include Tevard Biosciences, Excision BioTherapeutics, Locanabio, Inc., EmendoBio, Tessera Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alia Therapeutics and Tevard Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Alia Therapeutics, https://bouncewatch.com/company/alia-therapeutics, updated 19 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout